Pancreatic Cancer

A genetic counselor discussed the various hereditary breast and ovarian cancer syndrome-associated cancers among men and how to manage them at the FORCE Annual Meeting.

Pancreatic cancer is a silent killer in that symptoms usually start appearing after the cancer has advanced to a stage 3 or stage 2 level.

“Sometimes ‘a new normal’ seems to have a bad connotation,” said Nicole Lise Feingold, director of Patient Services at the Pancreatic Cancer Action Network (PanCAN).

After losing her husband and sister to cancer, journalist Katie Couric became an advocate for collaborative efforts to improve prevention and treatment.

Genetic testing is becoming more important in pancreatic cancer, especially since it can point toward more efficacious treatment regimens for some patients.

Tests like these are growing increasingly important, as TOO results lead to treatment changes about 65 percent of the time and a site treatment change about 35 percent of the time, according to Cancer Genetics.

A leader of the Pancreatic Cancer Action Network, which aims to double survival rates by 2020, outlines treatment strategies that could lead to success.

“Disease control is key in our patients with locally advanced disease, as it may lead to opportunities for additional treatment interventions, including radiotherapy, or even, in some favorable cases, surgical resection,” said lead study author Pascal Hammel, M.D., Ph.D.

“There have been significant developments in our underpinnings for the development of pancreas cancer on both a molecular and genetic basis," said Eileen M. O'Reilly, M.D.

Nutrition plays a crucial role in the lives of people with cancer. But more than a million people suffering from the disease in the United States also endure a wasting syndrome called cachexia.

What role will immunotherapy play in the future treatment of GI cancers? CURE spoke to Brian Hemphill, M.D., to find out.

Experimental treatment uses engineered T cells to target prostate stem cell antigen.

A regimen without gemcitabine had promising survival rates for patients with metastatic pancreatic cancer, according to a recent study.

There were promising results when Abraxane was added to standard therapy to treat pancreatic cancer.

CURE spoke with Jason Luke, M.D., about some of the pressing topics in the field of immunotherapy.

A recent study found that taking asprin daily may reduce the chance of developing pancreatic cancer.

Faced with cancer, some launch nonprofit organizations designed to help fellow patients and their families. Here’s how they do it.

Nutrition, though often overlooked, plays a key role in mitigating the symptom burden of patients with pancreatic cancer.

Murray Korc, M.D., of the IUPUI Pancreatic Cancer Signature Center, said that the future holds drastic changes for the treatment of pancreatic cancer.

Patients and providers shared inspiring stories of hope, as well as some tips for better living at the Seventh Annual Ruesch Center Symposium: Fighting a Smarter War on Cancer.

Recent-onset diabetes can lead to poorer outcomes in pancreatic cancer, according to a recent study.

After being diagnosed with pancreatic cancer, a PR executive created on online database where patients can connect with others who share their diagnosis and also get reliable information.

Eileen O'Reilly discusses the current barriers in treating pancreatic cancer, as well as what she sees for the future of the disease.